Proteomics analysis of cells incubated with R-enantiomer of warfarin, an anti-coagulating drug
Proteomics analysis of individual chiral drugs is a relatively novel idea in the research field and although warfarin is a standard anticoagulant and widely used in medical field, its narrow therapeutic range makes it hard to determine an accurate dosage. This study thus aims to provide a better...
| Main Author: | |
|---|---|
| Other Authors: | |
| Format: | Final Year Project (FYP) |
| Language: | English |
| Published: |
2009
|
| Subjects: | |
| Online Access: | http://hdl.handle.net/10356/16362 |
| _version_ | 1826120340750729216 |
|---|---|
| author | Teo, Kathrine Wei Shi. |
| author2 | Chen Wei Ning, William |
| author_facet | Chen Wei Ning, William Teo, Kathrine Wei Shi. |
| author_sort | Teo, Kathrine Wei Shi. |
| collection | NTU |
| description | Proteomics analysis of individual chiral drugs is a relatively novel idea in the research
field and although warfarin is a standard anticoagulant and widely used in medical
field, its narrow therapeutic range makes it hard to determine an accurate dosage. This
study thus aims to provide a better understanding and perspective of warfarin and
reduction of its potential side effects. Subcultured HepG2 liver cells were treated with
20uM of warfarin and the cytotoxicity level of warfarin was determined by MTT assay.
Sample of cells treated with warfarin was then labeled with iTRAQTM Reagents 117 (for
R-warfarin) before injecting into iTRAQ-coupled two dimension liquid chromatographymass
spectrometry (LC/MS-MS). Control cells treated with no drug were labeled with
iTRAQ 114. iTRAQ analysis identified 350 unique proteins based on evaluative criteria
(cutoff protein score of more than 2). Up or down regulation of the proteins were
further analysed using online Swiss-Prot database. Since these proteins induce cellular
change towards warfarin, they may be related to the action of warfarin drug. As
supported by previous literature reviews, R-warfarin was found to be less active than Swarfarin. |
| first_indexed | 2024-10-01T05:14:34Z |
| format | Final Year Project (FYP) |
| id | ntu-10356/16362 |
| institution | Nanyang Technological University |
| language | English |
| last_indexed | 2024-10-01T05:14:34Z |
| publishDate | 2009 |
| record_format | dspace |
| spelling | ntu-10356/163622023-03-03T15:36:00Z Proteomics analysis of cells incubated with R-enantiomer of warfarin, an anti-coagulating drug Teo, Kathrine Wei Shi. Chen Wei Ning, William School of Chemical and Biomedical Engineering DRNTU::Engineering::Chemical engineering::Biochemical engineering Proteomics analysis of individual chiral drugs is a relatively novel idea in the research field and although warfarin is a standard anticoagulant and widely used in medical field, its narrow therapeutic range makes it hard to determine an accurate dosage. This study thus aims to provide a better understanding and perspective of warfarin and reduction of its potential side effects. Subcultured HepG2 liver cells were treated with 20uM of warfarin and the cytotoxicity level of warfarin was determined by MTT assay. Sample of cells treated with warfarin was then labeled with iTRAQTM Reagents 117 (for R-warfarin) before injecting into iTRAQ-coupled two dimension liquid chromatographymass spectrometry (LC/MS-MS). Control cells treated with no drug were labeled with iTRAQ 114. iTRAQ analysis identified 350 unique proteins based on evaluative criteria (cutoff protein score of more than 2). Up or down regulation of the proteins were further analysed using online Swiss-Prot database. Since these proteins induce cellular change towards warfarin, they may be related to the action of warfarin drug. As supported by previous literature reviews, R-warfarin was found to be less active than Swarfarin. Bachelor of Engineering (Chemical and Biomolecular Engineering) 2009-05-25T08:00:39Z 2009-05-25T08:00:39Z 2009 2009 Final Year Project (FYP) http://hdl.handle.net/10356/16362 en Nanyang Technological University 63 p. application/pdf |
| spellingShingle | DRNTU::Engineering::Chemical engineering::Biochemical engineering Teo, Kathrine Wei Shi. Proteomics analysis of cells incubated with R-enantiomer of warfarin, an anti-coagulating drug |
| title | Proteomics analysis of cells incubated with R-enantiomer of warfarin, an anti-coagulating drug |
| title_full | Proteomics analysis of cells incubated with R-enantiomer of warfarin, an anti-coagulating drug |
| title_fullStr | Proteomics analysis of cells incubated with R-enantiomer of warfarin, an anti-coagulating drug |
| title_full_unstemmed | Proteomics analysis of cells incubated with R-enantiomer of warfarin, an anti-coagulating drug |
| title_short | Proteomics analysis of cells incubated with R-enantiomer of warfarin, an anti-coagulating drug |
| title_sort | proteomics analysis of cells incubated with r enantiomer of warfarin an anti coagulating drug |
| topic | DRNTU::Engineering::Chemical engineering::Biochemical engineering |
| url | http://hdl.handle.net/10356/16362 |
| work_keys_str_mv | AT teokathrineweishi proteomicsanalysisofcellsincubatedwithrenantiomerofwarfarinananticoagulatingdrug |